The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Anthera | Common | 03674U201 | 2,667 | 437,994 | SH | DFND | 437,994 | 0 | 0 | ||
Cempra | Common | 15130J109 | 10,685 | 383,935 | SH | DFND | 383,935 | 0 | 0 | ||
Chemocentryx | Common | 16383L106 | 1,296 | 215,000 | SH | DFND | 215,000 | 0 | 0 | ||
Chiasma | Common | 16706W102 | 41,362 | 2,080,595 | SH | DFND | 2,080,595 | 0 | 0 | ||
Cymabay | Common | 23257D103 | 3,072 | 1,600,000 | SH | DFND | 1,600,000 | 0 | 0 | ||
Dermira | Common | 24983L104 | 1,624 | 70,000 | SH | DFND | 70,000 | 0 | 0 | ||
Dicerna | Common | 253031108 | 7,755 | 945,757 | SH | DFND | 945,757 | 0 | 0 | ||
Epirus Biopharma | Common | 29428P107 | 35 | 7,896 | SH | DFND | 7,896 | 0 | 0 | ||
Flex Pharma | Common | 33938A105 | 120 | 10,000 | SH | DFND | 10,000 | 0 | 0 | ||
Innocoll | Common | 45780Q103 | 6,689 | 555,555 | SH | DFND | 555,555 | 0 | 0 | ||
Lombard Medical | Common | G55598109 | 12,331 | 3,473,452 | SH | DFND | 3,473,452 | 0 | 0 | ||
Oncogenex Pharma | Common | 68230A106 | 1,334 | 603,740 | SH | DFND | 603,740 | 0 | 0 | ||
Paratek | Common | 699374302 | 24,701 | 1,301,413 | SH | DFND | 1,301,413 | 0 | 0 | ||
Proteon | Common | 74371L109 | 27,423 | 2,017,872 | SH | DFND | 2,017,872 | 0 | 0 | ||
Regulus | Common | 75915K101 | 2,138 | 327,350 | SH | DFND | 327,350 | 0 | 0 | ||
Sientra | Common | 82621J105 | 22,320 | 2,199,012 | SH | DFND | 2,199,012 | 0 | 0 | ||
Tobira | Spons ADR | 88883P101 | 5,657 | 589,244 | SH | DFND | 589,244 | 0 | 0 |